MetLife (MET) is a publicly traded Financial Services sector company. As of May 20, 2026, MET trades at $82.51 with a market cap of $52.38B and a P/E ratio of 15.88. MET moved +1.77% today. Year to date, MET is +0.93%; over the trailing twelve months it is +0.25%. Its 52-week range spans $65.21 to $89.05. Analyst consensus is strong buy with an average price target of $93.20. Rallies surfaces MET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MET financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MET recently traded at $82.51. Market cap is $52.38B. P/E ratio is 15.88. Revenue is $77.59B.
| Metric | Value |
|---|---|
| Price | $82.51 |
| Market Cap | $52.38B |
| P/E Ratio | 15.88 |
| EPS | $5.20 |
| Dividend Yield | 0.59% |
| 52-Week High | $89.05 |
| 52-Week Low | $65.21 |
| Volume | 2.09M |
| Avg Volume | 0 |
| Revenue (TTM) | $77.59B |
| Net Income | $3.62B |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $77.08B | $3.40B | $4.74 |
| 2023 | $66.91B | $1.60B | $1.82 |
| 2022 | $69.90B | $2.56B | $2.93 |
| 2021 | $71.08B | $6.58B | $7.36 |
11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $93.20.